There are 216 resources available
DRUP (Drug Repurposing) trial and beyond: Learning from DRUP 1.0
Presenter: Karlijn Verkerk
Session: New trial designs, new paths to drug registration
Resources:
Slides
Webcast
Fast-tracking preclinical research to pan-cancer trials: Success stories and less so
Presenter: Vivek Subbiah
Session: New trial designs, new paths to drug registration
Resources:
Slides
Webcast
Biomarker-driven immunotherapies: How relevant is being tumour type-specific?
Presenter: Aurélien Marabelle
Session: New trial designs, new paths to drug registration
Resources:
Slides
Webcast
Q&A
Presenter: Christoph Benedikt Westphalen
Session: New trial designs, new paths to drug registration
Resources:
Webcast
Towards harmonised design and interpretation of histology agnostic, biomarker driven trials: The ESMO Precision Medicine Working Group initiative
Presenter: Christoph Benedikt Westphalen
Session: New trial designs, new paths to drug registration
Resources:
Slides
Webcast
Q&A
Presenter: Elena Garralda
Session: New trial designs, new paths to drug registration
Resources:
Webcast
Welcome and objectives
Presenter: Joaquin Mateo
Session: RoadMAP to the Clinic 2023: From organ specific to biomarker driven drug development and approval
Resources:
Webcast
The current landscape of research and development (R&D) and approval of precision therapeutics: The challenge of optimisation
Presenter: Fabrice André
Session: RoadMAP to the Clinic 2023: From organ specific to biomarker driven drug development and approval
Resources:
Slides
Webcast
6O - Insights into tumour dissemination and progression using longitudinal imaging and ctDNA in the TRACERx lung cancer study
Presenter: Wing Kin Liu
Session: Proffered Paper session 2
Resources:
Abstract
7O - Molecular drivers and therapeutic targets for neuroendocrine transformation in lung cancer
Presenter: Triparna Sen
Session: Proffered Paper session 2
Resources:
Abstract